+919405117673
Pazopanib 400 mg Tablets Exporter from India | Global Supply by Cordium Pharmaceuticals Pvt Ltd |
Pazopanib 400 mg Tablets – Trusted Global Oncology Medicine Exporter

Cordium Pharmaceuticals Pvt Ltd is a leading global exporter from India specializing in high-quality oncology medicines including Pazopanib 400 mg Tablets, supplied with strict quality compliance and reliable international logistics.

We ensure fast and secure delivery worldwide to:
United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.

What is Pazopanib 400 mg Used For?

Pazopanib 400 mg Tablets are a prescription anti-cancer medication used in targeted therapy. It belongs to the class of tyrosine kinase inhibitors (TKIs) and is commonly prescribed for:

Advanced renal cell carcinoma (kidney cancer)
Soft tissue sarcoma treatment
Inhibiting tumor growth and reducing blood supply to cancer cells
Recommended Dosage
The usual adult dose is 400 mg to 800 mg once daily, as prescribed by an oncologist
Should be taken on an empty stomach (at least 1 hour before or 2 hours after food)
Dosage may vary depending on patient condition and medical supervision

āš ļø Strictly use under medical prescription only.

Possible Side Effects

Some patients may experience side effects such as:

High blood pressure
Fatigue and weakness
Diarrhea or stomach discomfort
Loss of appetite
Liver function changes
Hair color changes
Nausea or vomiting

Consult a healthcare professional immediately if severe reactions occur.

Global Export & Supply by Cordium Pharmaceuticals Pvt Ltd

We are committed to high-quality pharmaceutical exports from India with:

GMP-certified manufacturing partners
Secure packaging and cold-chain logistics (if required)
Fast international shipping
Regulatory-compliant documentation

šŸ“¦ Fast Delivery Available to:
USA | Germany | UK | Netherlands | South Africa | UAE | Brazil

Contact Us for Bulk Orders & Export Inquiries

šŸ“ž WhatsApp: +91-9405117673
šŸ“§ Email: info@cordiumpharma.com
Apr 18th, 2026 12:20 PM

Keywords